Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2127-2135

  Kamenicky, Peter ^a,c,d   Blanchard, Anne ^a,d,e   Frank, Michael ^a,e   Salenave, Sylvie ^a,c   Letierce, Alexia ^b   Azizi, Michel ^d,e,f   Lombès, Marc ^a,c,d   Chanson, Philippe ^a,c,d  

^a BICÊTRE HOSPITAL   (France)

^b Unité de Recherche Clinique   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMILORIDE; EPITHELIAL SODIUM CHANNEL; FUROSEMIDE; GROWTH HORMONE; POTASSIUM ION; RENIN; SODIUM ION; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BODY FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG HYPERSENSITIVITY; FEMALE; HIGH SODIUM INTAKE; HORMONE INHIBITION; HUMAN; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SODIUM ABSORPTION; TREATMENT RESPONSE;

ACROMEGALY; ALDOSTERONE; AMILORIDE; BODY FLUIDS; CROSS-OVER STUDIES; DIURETICS; EDEMA; EPITHELIAL SODIUM CHANNEL; FEMALE; FUROSEMIDE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PROSPECTIVE STUDIES; RENIN; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 79960082055     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0078     Document Type: Article

References (49)

1. Melmed S 2006 Medical progress: acromegaly. N Engl J Med 355: 2558-2573
2. Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J 2009 Pituitary tumours: acromegaly. Best Pract Res Clin Endocrinol Metab 23:555-574
3. Jenkins PJ, Sohaib SA, Akker S, Phillips RR, Spillane K, Wass JA, Monson JP, Grossman AB, Besser GM, Reznek RH 2000 The pathology of median neuropathy in acromegaly. Ann Intern Med 133: 197-201 (Pubitemid 30617058)
4. Gouya H, Vignaux O, Le Roux P, Chanson P, Bertherat J, Bertagna X, Legmann P 2008 Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath- hold MRI sequence. AJR Am J Roentgenol 190:1576-1582 (Pubitemid 351798528)
5. Ikkos D, Luft R, Sjogren B 1954 Body water and sodium in patients with acromegaly. J Clin Invest 33:989-994
6. Chanson P, Timsit J, Masquet C, Warnet A, Guillausseau PJ, Birman P, Harris AG, Lubetzki J 1990 Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med 113:921-925
7. Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM 2010 Mortality in patients with pituitary disease. Endocr Rev 31:301-342
8. Amato G, Mazziotti G, Rotondi M, Iorio S, Doga M, Sorvillo F, Manganella G, Di Salle F, Giustina A, Carella C 2002 Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Clin Endocrinol (Oxf) 56:65-71 (Pubitemid 34107323)
9. Hansen TK, Møller J, Thomsen K, Frandsen E, Dall R, Jørgensen JO, Christiansen JS 2001 Effects of growth hormone on renal tubular handling of sodium in healthy humans. Am J Physiol Endocrinol Metab 281:E1326-E1332
10. Hayes FJ, Fiad TM, McKenna TJ 1997 Activity of the renin-angiotensin- aldosterone axis is dependent on the occurrence of edema in growth hormone (GH)-deficient adults treated with GH. J Clin Endocrinol Metab 82:322-323 (Pubitemid 27021321)
11. Johannsson G, Sverrisdóttir YB, Ellegård L, Lundberg PA, HerlitzH 2002 GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis. J Clin Endocrinol Metab 87:1743-1749
12. Dimke H, Flyvbjerg A, Frische S 2007 Acute and chronic effects of growth hormone on renal regulation of electrolyte and water homeostasis. Growth Horm IGF Res 17:353-368 (Pubitemid 47336876)
13. Quigley R, Baum M 1991 Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 88:368-374
14. Johannsson G, Gibney J, Wolthers T, Leung KC, Ho KK 2005 Independent and combined effects of testosterone and growth hormoneon extracellular water in hypopituitary men. J Clin Endocrinol Metab 90:3989-3994 (Pubitemid 41065024)
15. Kamenicky P, Viengchareun S, Blanchard A, Meduri G, Zizzari P, Imbert-Teboul M, Doucet A, Chanson P, Lombès M 2008 Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology 149:3294-3305 (Pubitemid 351919590)
16. + channel is made of three homologous subunits. Nature 367:463-467
17. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA 1999 Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney. J Clin Invest 104:R19-R23 (Pubitemid 29536348)
18. Féraille E, Doucet A 2001 Sodium-potassium- adenosinetriphosphatase- dependent sodium transport in the kidney: hormonal control. Physiol Rev 81:345-418 (Pubitemid 32096179)
19. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529 (Pubitemid 32273628)
20. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S 2010 A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141-3148
21. Weiss P, Hersey RM, Dujovne CA, Bianchine JR 1969 The meetabolism of amiloride hydroloride in man. Clin Pharmacol Ther 10:401-406
22. Flouvat B, Roux A, Leneveu A, Prinseau J, Alexandre JA 1991 Combination of long-acting furosemide and instant-acting amiloride: pharmacokinetics and pharmacodynamics in human subjects. Fundam Clin Pharmacol 5:741-752
23. Blanchard A, Azizi M, Peyrard S, Stern N, Alhenc-Gelas F, Houillier P, Jeunemaitre X 2007 Partial human genetic deficiency in tissue kallikrein activity and renal calcium handling. Clin J Am Soc Nephrol 2:320-325
24. Baker E, Jeunemaitre X, Portal AJ, Grimbert P, Markandu N, Persu A, Corvol P, MacGregor G 1998 Abnormalities of nasal potential difference measurement in Liddle's syndrome. J Clin Invest 102: 10-14
25. Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougnères P, Chanson P 2009 D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. Eur J Endocrinol 161:231-235
26. Azizi M, Iturrioz X, Blanchard A, Peyrard S, De Mota N, Chartrel N, Vaudry H, Corvol P, Llorens-Cortes C 2008 Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol 19:1015-1024
27. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM 2004 Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 291:1342-1349
28. Ho KY, Weissberger AJ 1990 The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 39:133-137 (Pubitemid 20053270)
29. Hoffman DM, Crampton L, Sernia C, Nguyen TV, Ho KK 1996 Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab 81:1123-1128 (Pubitemid 26083980)
30. Møller J, Møller N, Frandsen E, Wolthers T, Jørgensen JO, Christiansen JS 1997 Blockade of the renin-angiotensin- aldosterone system prevents growth hormone-induced fluid retention in humans. Am J Physiol 272:E803-E808
31. Strauch G, Vallotton MB, Touitou Y, Bricaire H 1972 The reninangiotensin- aldosterone system in normotensive and hypertensive patients with acromegaly. N Engl J Med 287:795-799
32. Karlberg BE, Ottosson AM 1982 Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol 100:581-587 (Pubitemid 12089236)
33. Marks P, Vincent R, Wilson B, Delassale A 1984 Aldosterone in acromegaly. Am J Med Sci 287:16-19 (Pubitemid 14088382)
34. McKnight JA, McCance DR, Hadden DR, Kennedy L, Roberts G, Sheridan B, Atkinson AB 1989 Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegaly. Clin Endocrinol (Oxf) 31:431-438 (Pubitemid 19238226)
35. Kraatz C, Benker G, Weber F, Lüdecke D, Hirche H, Reinwein D 1990 Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system. Klin Wochenschr 68: 583-587 (Pubitemid 20207850)
36. Soszynski P, Slowinska-Srzednicka J, Zgliczynski S 1991 Plasma concentrations of atrial natriuretic hormone in acromegaly: relationship to hypertension. Acta Endocrinol (Copenh) 125:268-272
37. Scaroni C, Selice R, Benedini S, De Menis E, Arosio M, Ronchi C, Gasperi M, Manetti L, Arnaldi G, Polenta B, Boscaro M, Albiger N, Martino E, Mantero F 2008 Adrenal morpho-functional alterations in patients with acromegaly. J Endocrinol Invest 31:602-606
38. Bielohuby M, Roemmler J, Manolopoulou J, Johnsen I, Sawitzky M, Schopohl J, Reincke M, Wolf E, Hoeflich A, Bidlingmaier M 2009 Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice. Exp Biol Med (Maywood) 234:1002-1009
39. Møller J, Jørgensen JO, Møller N, Hansen KW, Pedersen EB, Christiansen JS 1991 Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab 72:768-772 (Pubitemid 21921763)
40. Dirsch VM, Wolf E, Wanke R, Schulz R, Hermanns W, Vollmar AM 1998 Effect of chronic GH overproduction on cardiac ANP expression and circulating ANP levels. Mol Cell Endocrinol 144:109-118 (Pubitemid 28491306)
41. Deray G, Chanson P, Maistre G, Warnet A, Eurin J, Barthelemy C, Masson F, Martinez F, Lubetzki J, Legrand JC, et al. 1990 Atrial natriuretic factor in patients with acromegaly. Eur J Clin Pharm 38:409-413 (Pubitemid 20181266)
42. Møller J 2003 Effects of growth hormone on fluid homeostasis. Clinical and experimental aspects. Growth HormI GF Res 13:55-74
43. Moller J, Frandsen E, Fisker S, Jorgensen JO, Christiansen JS 1996 Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin Endocrinol (Oxf) 44: 533-539 (Pubitemid 26168769)
44. Dimke H, Flyvbjerg A, Bourgeois S, Thomsen K, Frøkiaer J, Houillier P, Nielsen S, Frische S 2007 Acute growth hormone administration induces antidiuretic and antinatriuretic effects and increases phosphorylation of NKCC2. Am J Physiol Renal Physiol 292:F723-F735 (Pubitemid 46220541)
45. Tannen RL, Gerrits L 1986 Response of the renal K+-conserving mechanism to kaliuretic stimuli: evidence for a direct kaliuretic effect by furosemide. J Lab Clin Med 107:176-184 (Pubitemid 16161510)
46. Duc C, Farman N, Canessa CM, Bonvalet JP, Rossier BC 1994 Cell-specific expression of epithelial sodium channel α, β, and γ subunits in aldosterone-responsive epithelia from the rat: localization by in situ hybridization and immunocytochemistry. J Cell Biol 127:1907-1921
47. Escoubet B, Coureau C, Bonvalet JP, Farman N 1997 Noncoordinate regulation of epithelial Na channel and Na pump subunit mRNAs in kidney and colon by aldosterone. Am J Physiol 272: C1482-C1491
48. Farman N, Talbot CR, Boucher R, Fay M, Canessa C, Rossier B, Bonvalet JP 1997 Noncoordinated expression of α-, β-, and γ-subunit mRNAs of epithelial Na+ channel along rat respiratory tract. Am J Physiol 272:C131-C141 (Pubitemid 127749936)
49. Baker EH, Ireson NJ, Carney C, Markandu ND, MacGregor GA 2001 Transepithelial sodium absorption is increased in people of African origin. Hypertension 38:76-80